M Ostronoff

739 total citations
26 papers, 389 citations indexed

About

M Ostronoff is a scholar working on Surgery, Hematology and Neurology. According to data from OpenAlex, M Ostronoff has authored 26 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Hematology and 6 papers in Neurology. Recurrent topics in M Ostronoff's work include Testicular diseases and treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Neuroblastoma Research and Treatments (4 papers). M Ostronoff is often cited by papers focused on Testicular diseases and treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Neuroblastoma Research and Treatments (4 papers). M Ostronoff collaborates with scholars based in France, Brazil and Paraguay. M Ostronoff's co-authors include Carole Soussain, Françoise Rigal‐Huguet, JL Harousseau, P. Y. Leprise, Sylvie François, P Cony-Makhoul, Alain Delmer, Catherine Patte, Nathalie Cambier and D Baume and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

M Ostronoff

25 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Ostronoff France 11 144 136 125 123 77 26 389
D Valteau France 13 67 0.5× 173 1.3× 61 0.5× 198 1.6× 97 1.3× 20 497
Jay E. Gold United States 13 151 1.0× 67 0.5× 53 0.4× 235 1.9× 50 0.6× 21 418
P. Spaander Netherlands 10 136 0.9× 44 0.3× 61 0.5× 108 0.9× 54 0.7× 18 333
Francesco Volzone Italy 8 140 1.0× 48 0.4× 62 0.5× 98 0.8× 60 0.8× 17 260
J.P. Merlio France 9 120 0.8× 40 0.3× 51 0.4× 64 0.5× 67 0.9× 21 292
Rafael Carrión Spain 9 238 1.7× 43 0.3× 86 0.7× 165 1.3× 68 0.9× 20 371
Michela Cerno Italy 14 149 1.0× 56 0.4× 64 0.5× 234 1.9× 372 4.8× 32 653
Vico Vecchi Italy 12 126 0.9× 105 0.8× 24 0.2× 71 0.6× 127 1.6× 28 417
Juichi Tanabe Japan 12 70 0.5× 45 0.3× 57 0.5× 62 0.5× 235 3.1× 25 417
B. Dörken Germany 7 86 0.6× 34 0.3× 38 0.3× 98 0.8× 108 1.4× 22 384

Countries citing papers authored by M Ostronoff

Since Specialization
Citations

This map shows the geographic impact of M Ostronoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ostronoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ostronoff more than expected).

Fields of papers citing papers by M Ostronoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ostronoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ostronoff. The network helps show where M Ostronoff may publish in the future.

Co-authorship network of co-authors of M Ostronoff

This figure shows the co-authorship network connecting the top 25 collaborators of M Ostronoff. A scholar is included among the top collaborators of M Ostronoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ostronoff. M Ostronoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Ostronoff, Fabiana, et al.. (2009). Coexistence of Leishmaniasis and Hodgkin's Lymphoma in a Lymph Node. Journal of Clinical Oncology. 27(32). e184–e185. 13 indexed citations
5.
Ostronoff, M, et al.. (2006). Pilot Study of Allogeneic G-CSF–Stimulated Bone Marrow Transplantation: Harvest, Engraftment, and Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 12(7). 729–733. 9 indexed citations
6.
Ostronoff, Fabiana, et al.. (2006). Safety of fractionated dose of rituximab in renal failure patients receiving hemodialysis. Leukemia & lymphoma. -1(1). 0–0. 5 indexed citations
7.
Voltarelli, Júlio César, Ana Beatriz P. L. Stracieri, Maria Carolina Oliveira, et al.. (2005). Transplante de células-tronco hematopoéticas em doenças reumáticas. Parte 2: experiência brasileira e perspectivas futuras. Revista Brasileira de Reumatologia. 45(5). 3 indexed citations
8.
Machado, Clarisse Martins, et al.. (1998). Primary Pneumocystis carinii Prophylaxis with Aerosolized Pentamidine after Bone Marrow Transplantation. Acta Haematologica. 99(1). 54–56. 16 indexed citations
9.
Castelli, Jussara Bianchi, et al.. (1997). Clinical features and successful recovery from disseminated nocardiosis after BMT. Bone Marrow Transplantation. 19(1). 81–82. 11 indexed citations
10.
Mendrone, Alfredo, et al.. (1997). Criopreservação de medula óssea e células pluripotentes periféricas utilizando um congelador programável: experiência em 86 congelamentos. Revista da Associação Médica Brasileira. 43(2). 93–98. 7 indexed citations
11.
Ostronoff, M, et al.. (1997). Herpes Simplex Virus Shedding in Bone Marrow Transplant Recipients During Low-Dose Oral Acyclovir Prohylaxis.. PubMed. 1(1). 27–30. 1 indexed citations
12.
Ostronoff, M, Carole Soussain, Angel Moran, et al.. (1995). Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases.. PubMed. 37(5). 267–72. 8 indexed citations
13.
Soussain, Carole, Catherine Patte, M Ostronoff, et al.. (1995). Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood. 85(3). 664–674. 123 indexed citations
14.
Droz, J P, J. L. Pico, Mario Ghosn, et al.. (1992). A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.. PubMed. 79(5). 497–507. 26 indexed citations
15.
Droz, Jean‐Pierre, J. L. Pico, Mario Ghosn, et al.. (1991). Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer. European Journal of Cancer and Clinical Oncology. 27(7). 831–835. 36 indexed citations
16.
Ribrag, Vincent, Droz Jp, Carole Bouleuc, et al.. (1990). [Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].. PubMed. 19(27). 1263–6. 1 indexed citations
17.
Jp, Droz, Mario Ghosn, C Théodore, et al.. (1989). Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.. PubMed. 303. 739–47. 3 indexed citations
18.
Schlumberger, Martin, M Ostronoff, M. Bellaïche, et al.. (1988). 5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma. Cancer. 61(8). 1492–1494. 21 indexed citations
19.
Ghosn, Mario, J P Droz, Christine Théodore, et al.. (1988). Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimen. Cancer. 62(1). 24–27. 39 indexed citations
20.
Baume, D, M Ostronoff, F. Beaujean, et al.. (1987). [High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].. PubMed. 74(5). 587–95. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Valteau Breakdown of academic impact, for papers by Jay E. Gold Breakdown of academic impact, for papers by P. Spaander Breakdown of academic impact, for papers by Francesco Volzone Breakdown of academic impact, for papers by J.P. Merlio Breakdown of academic impact, for papers by Rafael Carrión Breakdown of academic impact, for papers by Michela Cerno Breakdown of academic impact, for papers by Vico Vecchi Breakdown of academic impact, for papers by Juichi Tanabe Breakdown of academic impact, for papers by B. Dörken
Rankless by CCL
2026